Fish oil is the world's best-selling supplement. The science is surprisingly clear about it: for one thing it works strongly, for the most popular goal it barely works at all.
🩺 Written by K.Y.J.A.M. Ho, MD PhD, medical specialist · reviewed by C. Pleiter, medical specialist · updated 25 August 2026 · last medically reviewed 25 August 2026 · sources & method · how we make this
If you eat fish once or twice a week, including one portion of oily fish, a standard fish-oil capsule will probably add little for your heart: the largest trials find little to no effect on heart attacks in healthy people. Where omega-3 does work strongly: high doses (2 to 4 grams of EPA and DHA per day) lower elevated triglycerides by roughly 20 to 30 percent, but that is a doctor's territory. For mood and joints the evidence is limited. And this is more relevant than it sounds: most people in Western countries do not meet the fish-intake guidelines, so if you rarely eat fish your intake is almost certainly below the recommendation. A basic dose (±250 to 500 mg of EPA plus DHA per day) is then a reasonable safety net, provided it is in a well-absorbed form (triglyceride form, taken with a meal containing fat).
Do the check (1 minute) or go straight to the science
Strong High doses lower elevated triglycerides 20-30% Strong Little to no effect on heart prevention in the general population Limited Effects on mood and joints are small Moderate Triglyceride form is absorbed better than ethyl ester
This is an indication based on general information, not personal medical advice. Ranges are averages from group studies, not a prediction for you.
This check gives an indication only. It is not a medical test and makes no diagnosis. Discuss any doubt or symptoms with your doctor.
We'll email you your result with the practical steps.
Omega-3 is a family of fatty acids. The two that really matter for your body, EPA and DHA, come mainly from oily fish. Your body barely makes them itself, they are building blocks for your brain and they play a role in your fat metabolism. So far everyone agrees. The question is whether a capsule of those fatty acids improves your health, and there the answer is surprisingly layered.
The biggest misunderstanding first. Fish oil is sold as protection for your heart, but the large lottery-style trials in which tens of thousands of healthy people took fish oil or a dummy capsule for years found little to no difference in heart attacks or deaths. If you are healthy and eat fish now and then, a standard capsule mainly buys you peace of mind.
Where omega-3 does convincingly work: elevated triglycerides, one of the blood fats your doctor measures. High doses of EPA and DHA, 2 to 4 grams per day, lower them by roughly 20 to 30 percent. That is not self-care but treatment: those doses, and the question of whether they would benefit you, belong with your doctor. One large trial with a concentrated EPA medicine even found a quarter fewer cardiovascular events in heart patients with elevated triglycerides, although that result is still scientifically contested and it is emphatically about a medicine, not the capsules from the drugstore.
And the rest? For mood, an EPA-rich supplement added to treatment seems to have a small effect; for stiff joints in rheumatoid arthritis a modest one. For healthy brains, better concentration or "general health" the evidence is thin. Honesty also belongs here: at high doses we see a slightly increased risk of atrial fibrillation, a heart rhythm disorder, and omega-3 mildly thins the blood.
How likely is this to be about you? More likely than you think. Most people in Western countries do not meet the guideline of weekly fish, and a global survey of blood levels places most of Europe in the low to moderate range for EPA plus DHA status in healthy adults. Researchers measure this with the omega-3 index: the share of EPA and DHA in the membrane of your red blood cells. Below 4 percent is associated in research with a higher risk of cardiac death, 8 percent or higher counts as the favourable range, and most people in Western countries sit well below that. How much this weighs was shown by the famous Framingham study: the omega-3 index predicted the risk of dying within eleven years about as strongly as the classic risk factors, smoking included, and in the survival estimates a smoker with a high omega-3 index came out comparable to a non-smoker with a low index. Read that carefully: it does not make smoking any less deadly, it makes too little omega-3 more serious. If you rarely eat fish, you are almost certainly too low.
How did we get here? In just over a century our fat pattern has completely flipped. With the rise of vegetable oils and margarines, omega-6 intake rose enormously while omega-3 stayed flat or fell; the omega-6 to omega-3 ratio shifted from somewhere between 1-to-1 and 4-to-1 in traditional diets to 15-to-1 or 20-to-1 in the modern Western diet. The bitter detail: many of those omega-6-rich margarines and oils were marketed precisely as "good for your heart". The researchers who study this ratio place the optimum around 1-to-1, with 4-to-1 as the upper bound; the major cardiology organisations use no ratio target and place the problem not with omega-6 but with the too-low omega-3 side. But note what can safely be said within that debate: wherever the optimum lies exactly, at 15-to-1 to 20-to-1 almost everyone sits far below it. And the fact that almost everyone sits there does not make it healthy: common is not the same as good, any more than excess weight became healthy once it became the norm. Our working position at DrHealthy is therefore practical: bring your ratio back towards 4-to-1 or better, in the direction of the traditional range. And you realistically close that gap on one side only: with more omega-3. Do not count on a margarine with a heart logo for that, but on fish, or a well-chosen capsule in the right form.
And then the point almost nobody tells you: not every capsule is equal. Omega-3 comes in supplements in different chemical forms. The natural triglyceride form (often "rTG" or "triglyceride" on labels) is absorbed clearly better than the cheaper ethyl-ester form ("EE"), which is poorly absorbed especially without a fatty meal. Krill oil contains omega-3 as phospholipids; that sounds advanced, but a proven clinical advantage does not exist and the amount of EPA and DHA per capsule is often low for a high price. Two practical rules catch almost everything: check the label for the form and the actual milligrams of EPA plus DHA, and always take your capsule with a meal containing fat.
Our honest advice is therefore the same as most guidelines: eat fish once or twice a week, including one portion of oily fish such as salmon, mackerel, herring or sardines. If that really does not work for you, a basic dose of 250 to 500 mg of EPA plus DHA per day (fish oil or algae oil, in triglyceride form, with food) is a reasonable safety net. Considering more than that, or using medication: your doctor first.
The ratio in the Western diet has indeed become heavily skewed (from roughly 1-4:1 historically to 15-20:1), mainly because omega-6 intake from oils and margarines exploded. Ratio researchers place the optimum around 1:1, with roughly 4:1 as the upper bound; the major guidelines use no ratio target. But wherever the optimum lies exactly: at 15-20:1 you sit far below it either way, and the fact that almost everyone sits there does not make it good. Aim for 4:1 or better, which in practice means focusing on getting more EPA and DHA, in the right form, rather than on calculating a fraction.
The natural triglyceride form (rTG or TG on the label) is absorbed better than the cheaper ethyl-ester form (EE), especially if you do not take the capsule with a fatty meal. So always take omega-3 with food, and when in doubt choose the triglyceride form. The phospholipid form from krill oil has no proven clinical advantage.
There is no convincing evidence for that. Krill oil is often more expensive per gram of EPA and DHA, and the large trials were done with regular fish oil or concentrated EPA. Look at the form and the amount of EPA plus DHA on the label, not at the source.
For general maintenance the European food safety authority EFSA uses 250 mg of EPA plus DHA per day as a reference, which you reach with one or two portions of oily fish per week. The high doses of 2 to 4 grams used in trials for elevated triglycerides belong with a doctor, not with self-care.
At normal doses it is safe. At high doses, large trials show a slightly increased risk of atrial fibrillation, and omega-3 has a mild blood-thinning effect. If you use blood thinners or have surgery coming up, talk to your doctor first.
Yes. Algae oil provides the same DHA, and often EPA as well, without fish. Check the label to see whether the daily dose provides at least roughly 250 mg of EPA plus DHA combined; contents vary widely between brands.
Evidence labels: Strong direct, consistent randomised trials or meta-analyses · Moderate randomised evidence with heterogeneity or limited applicability · Limited small, short or observational studies.
Triglycerides. Strong In people with elevated triglycerides, 2 to 4 grams of EPA plus DHA per day lowers fasting triglycerides by roughly 20 to 30 percent versus placebo (population: adults with hypertriglyceridaemia; net difference versus the control group; the effect is larger the higher the starting value) [1]. This is omega-3's best-supported effect.
Primary prevention of cardiovascular disease. Strong In VITAL (25,871 healthy adults, 1 gram of fish oil per day, median follow-up 5.3 years) the composite endpoint of heart attack, stroke and cardiovascular death did not differ significantly from placebo [2]. Nor did it in ASCEND (15,480 people with diabetes, 1 gram per day, 7.4 years) [3]. The 2020 Cochrane review (86 randomised trials, over 160,000 participants) concludes that extra EPA and DHA has little to no effect on mortality and cardiovascular disease in the broad population [4]. Note what this does and does not say: it concerns supplements on top of a normal diet, not eating fish itself.
The EPA exception, and why it is contested. Moderate REDUCE-IT (8,179 statin users with elevated triglycerides, 4 grams of concentrated icosapent ethyl per day, 4.9 years) found a 25 percent relative risk reduction in major cardiovascular events: in absolute terms from 22.0 to 17.2 percent over almost five years [5]. But STRENGTH, a similarly large trial with an EPA-DHA preparation, found nothing, and debate continues over whether the mineral-oil placebo in REDUCE-IT inflated the difference [6]. Moreover: these are registered medicines in high-risk study populations, not drugstore capsules for healthy people.
Atrial fibrillation, the honest downside. Moderate A meta-analysis of large randomised trials shows a dose-dependent increased risk of atrial fibrillation with omega-3 use, especially above 1 gram per day (relative risk around 1.25 versus placebo; absolute risks remain small but are real at high doses) [7].
Mood. Limited Meta-analyses of smaller trials suggest that EPA-rich preparations added to depression treatment may have a small beneficial effect; the studies are heterogeneous and often short [8]. Omega-3 is not a treatment for depression; always discuss symptoms with your doctor.
Joints. Limited In rheumatoid arthritis, meta-analyses show a modest reduction in pain and morning stiffness; effects on the disease process itself have not been demonstrated [9].
Diet and guidelines. Dietary guidelines advise weekly fish, preferably oily fish; the European food safety authority EFSA uses 250 mg of EPA plus DHA per day as a reference for the maintenance of normal heart function (authorised claim) [10, 11]. The difference between fish and pill matters: fish consumption is associated with lower risk in cohort studies, but people who eat fish also differ in other ways from people who do not; the controlled supplement trials above are the purest test of the capsule itself.
Intake and status: most people run low. Moderate Most people in Western countries do not meet the guideline of weekly fish (national food consumption surveys have shown average fish intake below the recommendation for years) [10]. A global survey of blood levels in healthy adults places most of Europe in the low to moderate range for EPA plus DHA status [12]. The omega-3 index (EPA plus DHA as a percentage of fatty acids in the red-blood-cell membrane) is the best-supported measure for this: an index below ±4 percent is associated in cohort research with an increased risk of coronary cardiac death, and ±8 percent or higher with the lowest risk [16]. In the Framingham Offspring cohort (2,240 participants without known cardiovascular disease, 11 years of follow-up), a set of fatty-acid measures including the omega-3 index predicted the risk of death at least as well as the eight classic risk factors combined, smoking included, and the estimated survival curves showed smokers with a high omega-3 index coming out comparable to non-smokers with a low index [20]. This is observational and therefore emphatically not a licence: smoking remains the largest avoidable cause of death and quitting delivers more than any supplement. But it underlines that a low omega-3 status is no minor detail. Honest framing: this is an association measure from observational research, not an official clinical deficiency threshold, and that supplementing towards a higher index improves hard outcomes has not been conclusively shown by the prevention trials above. That the status of most Westerners is low is not in dispute.
The omega-6 ratio, treated honestly. Moderate Descriptively it is established: intake of omega-6 (mainly linoleic acid from vegetable oils and margarines) rose sharply during the twentieth century, shifting the omega-6 to omega-3 ratio from an estimated 1-4:1 in traditional diets to 15-20:1 in the modern Western diet [17, 18]. Limited The ratio hypothesis places the optimum around 1:1, with roughly 4:1 as the upper bound of the favourable range, based on evolutionary and mechanistic arguments [18]; that estimate has not been adopted by the major guidelines, and an AHA advisory concluded that omega-6 intake within usual amounts is not harmful and that replacing saturated fat with linoleic acid tends to lower risk [19]. The absence of a guideline norm does not refute the hypothesis; it means the burden of proof for a hard ratio target has not yet been met. What is beyond dispute, whichever camp turns out to be right: at the Western 15-20:1, almost everyone sits far below any proposed optimum. That this has become the norm is no argument for staying there; common is not the same as good. Our working position at DrHealthy: aim for 4:1 or better, towards the traditional range, and the realistic correction sits on the omega-3 side: raising EPA plus DHA intake, in a well-absorbed form, rather than trusting omega-6-rich products with a health logo.
Form and absorption: not every capsule is equal. Moderate In comparative research, the re-esterified triglyceride form was absorbed best (bioavailability around 124 percent relative to standard fish oil) and the ethyl-ester form worst (around 73 percent) [13]; in a direct comparison the omega-3 index rose more after six months on the triglyceride form than on the same dose as ethyl ester [14]. Absorption of ethyl esters also depends strongly on fat intake at the same time: with a fatty meal the gap narrows, on an empty stomach it is large [15]. Limited For the phospholipid form (krill oil), manufacturers claim better absorption, but the studies are small, often not dose-matched, and a clinically relevant advantage has not been demonstrated; EPA plus DHA content per capsule is usually low [15]. Practical translation: choose the triglyceride form, or take ethyl esters only with a meal containing fat, and always count the milligrams of EPA plus DHA on the label.
Practical, up to the line. Basis: 1 to 2 portions of fish per week, 1 of them oily. No fish: 250 to 500 mg of EPA plus DHA per day from fish oil or algae oil, in triglyceride form and with a meal containing fat; choose a product that states its form and EPA and DHA content explicitly on the label. Elevated triglycerides, heart medication, blood thinners, pregnancy or planned surgery: the choice and dose belong with your own doctor. Whether high-dose EPA makes sense for your situation is for a doctor to judge in a personal consultation.